| Jason Burdick |
Penn Spin-off Company (Unnamed) |
New treatments for congestive heart failure |
| Russell J. Composto |
Coulter commercialization grant for vascular graft material held jointly with Drexel |
Longer lasting grafts for coronary artery bypass and lower limb ischemia |
| Scott Diamond |
Reaction Biology |
Tools for nanoscale high throughput drug screening |
| Paul Ducheyne |
OrthoVita and Gentis |
Orthopedic implants and tissue engineering |
| Paul A. Janmey |
Critical Biologics |
New biologic for treating toxic shock |
| Brian Litt |
NeuroPace; MC10 |
Implantable tools and computer algorithms for predicting epileptic seizures and sudden cardiac death |